Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Shimada

Showing results (181-190 of 365) with videos related to

Pageof 37
Sort By:
Plos One|January 9, 2015
Gene therapy of c-myc suppressor FUSE-binding protein-interacting repressor by Sendai virus delivery prevents tracheal stenosisDaisuke Mizokami, Koji Araki, Nobuaki Tanaka, et al.
Springerplus|March 31, 2016
An intrapleural administration of zoledronic acid for inoperable malignant mesothelioma patients: a phase I clinical study protocolYuji Tada, Kenzo Hiroshima, Hideaki Shimada, et al.
Hepato-Gastroenterology|February 21, 2015
Potential tumor spread of lateral pelvic lymphatic flow in low rectal cancerKimihiko Funahashi, Junichi Koike, Hiroyuki Shiokawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[An analysis of cases with malignant pyloroduodenal obstruction from unresectable pancreatic cancer who underwent palliative gastrojejunostomy]Takamaru Koda, Tetsuya Maeda, Masaru Tsuchiya, et al.
Annals of Gastroenterological Surgery|June 4, 2020
Prognostic impact of p53 and/or NY-ESO-1 autoantibody induction in patients with gastroenterological cancersIsamu Hoshino, Yoshihiro Nabeya, Nobuhiro Takiguchi, et al.
Molecular and Clinical Oncology|May 15, 2025
Low prealbumin level is a poor prognostic biomarker for surgically treated pancreatic cancerYu Matsumoto, Yuichiro Otsuka, Hiroka Hosaka, et al.
Surgery Today|April 23, 2025
Association between the preoperative Midkine (+)/CEA (+) level and poor prognosis in colorectal cancer patientsMitsunori Ushigome, Hideaki Shimada, Masaaki Ito, et al.
Hepato-Gastroenterology|June 22, 2005
Evaluation of Ki-67 and p53 expression in primary and repeated liver metastases of GISTsYoshio Gunji, Takashi Nikaidou, Sinichi Okazumi, et al.
Frontiers in Oncology|June 3, 2022
Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and AtherosclerosisLiubing Hu, Jiyue Liu, Hideaki Shimada, et al.
Journal of the American College of Surgeons|January 9, 2003
Sentinel lymph node mapping for gastric cancer using a dual procedure with dye- and gamma probe-guided techniquesHideki Hayashi, Takenori Ochiai, Mikito Mori, et al.
Pageof 37

Showing results (181-190 of 365) with videos related to

Sort By:
Pageof 37
Plos One|January 9, 2015
Gene therapy of c-myc suppressor FUSE-binding protein-interacting repressor by Sendai virus delivery prevents tracheal stenosisDaisuke Mizokami, Koji Araki, Nobuaki Tanaka, et al.
Springerplus|March 31, 2016
An intrapleural administration of zoledronic acid for inoperable malignant mesothelioma patients: a phase I clinical study protocolYuji Tada, Kenzo Hiroshima, Hideaki Shimada, et al.
Hepato-Gastroenterology|February 21, 2015
Potential tumor spread of lateral pelvic lymphatic flow in low rectal cancerKimihiko Funahashi, Junichi Koike, Hiroyuki Shiokawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[An analysis of cases with malignant pyloroduodenal obstruction from unresectable pancreatic cancer who underwent palliative gastrojejunostomy]Takamaru Koda, Tetsuya Maeda, Masaru Tsuchiya, et al.
Annals of Gastroenterological Surgery|June 4, 2020
Prognostic impact of p53 and/or NY-ESO-1 autoantibody induction in patients with gastroenterological cancersIsamu Hoshino, Yoshihiro Nabeya, Nobuhiro Takiguchi, et al.
Molecular and Clinical Oncology|May 15, 2025
Low prealbumin level is a poor prognostic biomarker for surgically treated pancreatic cancerYu Matsumoto, Yuichiro Otsuka, Hiroka Hosaka, et al.
Surgery Today|April 23, 2025
Association between the preoperative Midkine (+)/CEA (+) level and poor prognosis in colorectal cancer patientsMitsunori Ushigome, Hideaki Shimada, Masaaki Ito, et al.
Hepato-Gastroenterology|June 22, 2005
Evaluation of Ki-67 and p53 expression in primary and repeated liver metastases of GISTsYoshio Gunji, Takashi Nikaidou, Sinichi Okazumi, et al.
Frontiers in Oncology|June 3, 2022
Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and AtherosclerosisLiubing Hu, Jiyue Liu, Hideaki Shimada, et al.
Journal of the American College of Surgeons|January 9, 2003
Sentinel lymph node mapping for gastric cancer using a dual procedure with dye- and gamma probe-guided techniquesHideki Hayashi, Takenori Ochiai, Mikito Mori, et al.
Pageof 37